Status:
COMPLETED
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
Lead Sponsor:
Alcon Research
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study was to describe the ocular discomfort immediately upon instillation of Brinzolamide 1%/Brimonidine 0.2% Tartrate Ophthalmic Suspension, Brinzolamide 1% Ophthalmic Suspension,...
Eligibility Criteria
Inclusion
- Sign Informed Consent document.
- Diagnosis of open-angle glaucoma or ocular hypertension
- Other protocol-specified inclusion criteria may apply.
Exclusion
- Females of childbearing potential if pregnant, lactating, or not using highly effective birth control measures.
- Severe central vision loss in either eye.
- Any chronic or recurrent inflammatory eye disease.
- Ocular trauma within the preceding 6 months.
- Ocular infection or ocular inflammation within the preceding 3 months.
- Best-corrected visual acuity score worse than 55 letters using the Early Treatment Diabetic Retinopathy Study chart.
- Any intraocular surgery within the preceding 6 months.
- Any ocular laser surgery within the preceding 3 months.
- History or current evidence of severe illness or any other conditions which would make the subject, in the opinion of the Investigator, unsuitable for the study.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT01426867
Start Date
September 1 2011
End Date
November 1 2011
Last Update
July 8 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.